• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600LDS26A
Device Problem Failure to Align (2522)
Patient Problem Insufficient Information (4580)
Event Date 01/24/2023
Event Type  malfunction  
Event Description
As reported by the edwards field clinical specialist, during a transcatheter aortic valve replacement case with a 26mm sapien 3 valve, once the valve crossed the aortic valve, it was noted that the valve was not completely aligned on the balloon, but the decision was made to deploy.Once rapid pacing was initiated, the valve dove slightly into the ventricle.As the physician was deploying the valve, the valve embolized into the ventricle.The decision was made to open the patient, retrieve the sapien 3 valve, and implant a surgical valve.The patient had been prepped and draped in normal sterile fashion.The right axillary artery was accessed.The esheath+ was advanced into descending aorta.Device and delivery system were prepped in accordance with the ifu.The device was delivered to the ascending aorta and valve alignment was performed with the valve 0.5mm above the distal marker.The team released all the tension prior to deployment.There were no issues with alignment.There was no allegation of malfunction by the operator.
 
Manufacturer Narrative
Investigation is ongoing.
 
Manufacturer Narrative
Updated h6-type of investigation, investigation findings, investigation conclusions.The device was not returned for evaluation.3mensio was provided and the following were observed: calcification and tortuosity were in access vessels present within the patient's anatomy.Calcification was present within the patient's aorta.The complaint for valve not being aligned between markers and deployed was unable to be confirmed as neither the complaint device nor applicable imagery was provided for evaluation.Due to the unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis.Therefore, a manufacturing non-conformance was unable to be determined.Due to unavailability of work order review of the dhr, lot history was not performed.Additionally, a review of the ifu and training manuals revealed no deficiencies.A review of edwards lifesciences risk management documentation was performed for this case.The reported events are an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure modes is not required at this time.As reported , "once the valve crossed the aortic valve, it was noted that the valve was not completely aligned on the balloon.The valve dove slightly into the ventricle.Per case notes provided, they mentioned that there were no issues with alignment.Per training manual, "before deployment, ensure that the valve is correctly positioned between the valve alignment markers and the flex catheter tip is over the triple marker".Failure to follow instructions can result in improper deployment.Due to the valve not properly aligned between valve alignment markers the balloon inflated distally and led to the dislodgment.As such, available information suggests that procedural factors (misaligned valve on inflation balloon prior to deployment) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16383171
MDR Text Key309662748
Report Number2015691-2023-10836
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9600LDS26A
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/24/2023
Initial Date FDA Received02/15/2023
Supplement Dates Manufacturer Received03/30/2023
Supplement Dates FDA Received03/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-